Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darunavir/ritonavir + rilpivirine dual therapy versus triple therapy maintenance study in virologically suppressed HIV infection
2012-005192-14Phase 3Active
- Sponsor
- Luigi Sacco University Hospital
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of darunavir, ritonavir, rilpivirine in human immunodeficiency virus infection (HIV), sponsored by Luigi Sacco University Hospital. Started Dec 2012; status: active.
02
Drugs
darunavirritonavirrilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2012-005192-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005192-14.